Your browser doesn't support javascript.
loading
Primary refractory multiple myeloma: a real-world experience with 85 cases.
Jurczyszyn, Artur; Waszczuk-Gajda, Anna; Castillo, Jorge J; Krawczyk, Katarzyna; Stork, Martin; Pour, Ludek; Usnarska-Zubkiewicz, Lidia; Potoczek, Stanislaw; Hus, Iwona; Davila Valls, Julio; Hari, Parameswaran; Chhabra, Saurabh; Gentile, Massimo; Mikala, Gabor; Varga, Gergely; Chim, Chor Sang; Fiala, Mark; Vij, Ravi; Schutz, Natalia; Rodzaj, Marek; Porowska, Agnieszka; Vesole, David H; Druzd-Sitek, Agnieszka; Walewski, Jan; Nooka, Ajay K.
Afiliação
  • Jurczyszyn A; Department of Hematology, Jagiellonian University Medical College, Cracow, Poland.
  • Waszczuk-Gajda A; Department of Hematology, Oncology and Internal Medicine, Warsaw Medical University, Warsaw, Poland.
  • Castillo JJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Krawczyk K; Department of Hematology, Jagiellonian University Medical College, Cracow, Poland.
  • Stork M; Department of Internal Medicine, Hematology and Oncology, University Hospital, Brno, Czech Republic.
  • Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital, Brno, Czech Republic.
  • Usnarska-Zubkiewicz L; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Potoczek S; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Hus I; Medical University of Lublin, Lublin Poland.
  • Davila Valls J; Complejo Asistencial de Avila, Avila, Spain.
  • Hari P; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Chhabra S; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Gentile M; Hematology Unit of Cosenza, Italy.
  • Mikala G; Department of Hematology and Stem Cell Transplantation, South-Pest Central Hospital, National Institute of Hematology and Infectology, Budapest, Hungary.
  • Varga G; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Chim CS; Division of Hematology and Medical Oncology, Queen Mary Hospital, Hong Kong, China.
  • Fiala M; Washington University School of Medicine, St. Louis, MS, USA.
  • Vij R; Washington University School of Medicine, St. Louis, MS, USA.
  • Schutz N; Department of Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Rodzaj M; Department of Hematology, Regional Specialistic Hospital, Cracow, Poland.
  • Porowska A; Department of Oncology and Haematology, Central Clinical Hospital of the Ministry of the Interior, Warsaw, Poland.
  • Vesole DH; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
  • Druzd-Sitek A; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Walewski J; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Nooka AK; School of Medicine, Emory University, Atlanta, GA, USA.
Leuk Lymphoma ; 61(12): 2868-2875, 2020 12.
Article em En | MEDLINE | ID: mdl-32623944
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article